Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Authors
Keywords
Resveratrol, Liver enzymes, Non-alcoholic fatty liver disease, Meta-Analysis
Journal
COMPLEMENTARY THERAPIES IN MEDICINE
Volume 57, Issue -, Pages 102635
Publisher
Elsevier BV
Online
2020-12-01
DOI
10.1016/j.ctim.2020.102635
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Established and emerging factors affecting the progression of nonalcoholic fatty liver disease
- (2020) Stergios Kechagias et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
- (2019) Jinchunzi Yang et al. Nutrients
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Are Lifestyle Therapies Effective for NAFLD Treatment?
- (2019) Nermeen N. El-Agroudy et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
- (2019) Golnaz Ranjbar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Somayyeh Asghari et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Effect of resveratrol on lipid profile: An updated systematic review and meta-analysis on randomized clinical trials
- (2018) Fahimeh Haghighatdoost et al. PHARMACOLOGICAL RESEARCH
- Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
- (2018) Yan-Lan Fang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- (2018) Mehdi Koushki et al. CLINICAL THERAPEUTICS
- Burden of Liver Diseases in the World
- (2018) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials
- (2018) Reza Tabrizi et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
- (2017) Hironori Kitade et al. Nutrients
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease
- (2016) Yoosoo Chang et al. Obesity
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Resveratrol and Cardiovascular Diseases
- (2016) Dominique Bonnefont-Rousselot Nutrients
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials
- (2014) Kai Liu et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Resveratrol and liver disease: from bench to bedside and community
- (2010) Anupam Bishayee et al. LIVER INTERNATIONAL
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD
- (2008) Kamran Qureshi et al. OBESITY SURGERY
- Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
- (2008) G MUSSO et al. PROGRESS IN LIPID RESEARCH
- Insulin resistance, inflammation, and non-alcoholic fatty liver disease
- (2008) Herbert Tilg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation